$8.20
Price
$301M
Market Cap
—
P/E Ratio
-5.2
Forward P/E
$-4.80
EPS (TTM)
—
Dividend Yield
$9M
Cash
$288M
Total Debt
37M
Shares Out
$1.17
$16.34
52-Week Range
Institutional Ownership of REATA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for REATA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2021-Q4 | |||||
| SELL | EXIT | — | — | $3.90 | |
| 2021-Q2 | |||||
| BUY | NEW | 2.0K | $283000 | $4.17 | |
| 2021-Q1 | |||||
| SELL | EXIT | — | — | $5.33 | |
| 2020-Q4 | |||||
| BUY | NEW | 2.0K | $247000 | $3.16 | |
| 2020-Q3 | |||||
| SELL | EXIT | — | — | $3.52 | |
| 2019-Q4 | |||||
| BUY | NEW | 2.0K | $409000 | $4.10 | |
Insider Trading for REATA PHARMACEUTICALS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.